Scientists from the Zoological Society of London (ZSL), the University of Leeds and the New York State Department of Health, together with the Galápagos National Park Service and University of Guayaquil, have been studying the disease threat posed by Islands' mosquito populations. They have discovered that a species of these biting insects is capable of transmitting West Nile virus, a potentially dangerous disease for the archipelago's unique wildlife.
West Nile virus (WNV) most commonly affects birds, but can infect mammals, including humans, and reptiles. Previous studies of West Nile virus impact in the USA have linked the virus to declines in several bird populations, demonstrating the high risk it poses to the Galápagos' endemic species. The virus recently invaded South America, but has yet to reach the Galápagos.
Recent studies on tourist boats and planes have shown that the mosquito species Culex quinquefasciatus (also known as the Southern house mosquito) is hitching a ride onto the Galápagos on airliners. Culex species are well-known vectors of WNV elsewhere in the world, so their presence on the Islands has caused concern amongst the scientific community.
The ability of mosquitoes to transmit particular disease agents effectively often varies between species, or between populations within species. Therefore to understand the risk posed by C. quinquefasciatus in Galápagos, the research team measured the ability of Galápagos C. quinquefasciatus to pick up and transmit WNV in the lab, under conditions that simulated those in the wild. They found that Galápagos C. quinquefasciatus were indeed effective vectors for the virus.
Prof Andrew Cunningham from ZSL says: "We now know that mosquitoes capable of carrying West Nile virus have a route onto the Galápagos, and once there, the virus could also spread into the local mosquito population. This means there is potential for large impacts on endemic species. There is no doubt that West Nile virus poses a serious threat to the survival of the Galápagos' iconic wildlife."
In order to reduce the chances of West Nile virus reaching the islands, the authors suggest further research to determine the presence of WNV in the mainland Ecuador, plus strict enforcement insect control measures on aircraft and ships moving between the mainland and islands.
Dr Simon Goodman from the University of Leeds says: "Piece by piece we are building up a comprehensive picture of the disease ecology in Galápagos and what could happen if WNV were to reach the islands. Once WNV has been introduced onto the Galápagos, it would be much harder to contain. Therefore the best strategy is to have strict preventive measures to reduce the chance of the disease reaching the islands in the first place."
Lead author PhD student Gillian Eastwood says: "Whilst WNV does not yet exist in Galápagos, it is important to envisage what future disease scenarios could be by looking at how this particular virus would interact within this unique ecosystem. Evaluating the role that mosquitoes could play is therefore vital. This recent part of our work is however only one aspect to understanding potential WNV transmission on the Islands; it remains to see how severely Galapagos wildlife might be affected but all precautions should be taken."
The research is published in the current edition of the American Journal of Tropical Medicine Hygiene.
Graham Askew, Simon Walker, BBSRC (Jan 2018), £699,781
Jennifer Tomlinson, Royal Society (Jan 2018), £512,801
Alex O'Neill and colleagues in Chemistry, BBSRC (Nov 2017), £431,865
Tom Bennett, BBSRC (Oct 2017), £523,679
Neil Ranson, Darren Tomlinson, BBSRC (Oct 2017), £494,318
Nikita Gamper, BBSRC (Oct 2017), £490,426
Amanda Bretman and colleagues from UEA, NERC (Oct 2017), £430,886
Juan Fontana, Rosetrees Trust consumables grant (Oct 2017), £22,500
Helen Miller, DSM Nutritional Products AG (Sep 2017), £69,988
Neil Ranson, Juan Fontana, Mark Harris, Michelle Peckham, Ralf Richter, Peter Stockley, Patricija Van Oosten-Hawle and colleagues in Engineering, FMH and MAPS, Wellcome Trust Equipment Call (Sep 2017), £418,000
Jamie Johnston, Physiological Society (Sep 2017), £10,000
Frank Sobott, Adrian Goldman, Mark Harris, Andrew Macdonald, Stephen Muench, Sheena Radford and colleagues in FMH and MAPS, Wellcome Trust Equipment Call (Aug 2017), £415,000
Ralf Richter, David Brockwell, Eric Hewitt, Jessica Kwok, Emanuele Paci and MAPS/FMH, BBSRC (Jun 2017), £600,000
Eric Blair, Adrian Whitehouse, Nicola Stonehouse, Alison Baker, Richard Bayliss, Joan Boyes, Ryan Seipke, Sally Boxall and MAPS/FMH, BBSRC (Jun 2017), £376,000
Stefan Kepinski, Yoselin Benitez-Alfonso, Tom Bennett, Michelle Peckham, BBSRC (Jun 2017), £331,000
Roman Tuma, Lars Jeuken, Paul Millner, Sheena Radford, Peter Stockley and MAPS/FMH, BBSRC (Jun 2017), £222,000
Vas Ponnambalam, Darren Tomlinson, Stephen Wheatcroft, BHF (May 2017), £107,878
Graham Askew in collaboration with Bangor University, BBSRC (Mar 2017), £477,383
Stephen Muench, BBSRC (Mar 2017), £132,945
Nic Stonehouse, MRC (Mar 2017), £906,341
Bill Kunin, Steve Sait, BBSRC (Mar 2017), £602,831
Adrian Goldman, EU (Mar 2017), £546,576
Sheena Radford, Wellcome Trust (Mar 2017), £1,836,482
Jamie Johnston, Royal Society (Mar 2017), £15,000
Beatrice Filippi, Royal Society (Mar 2017), £15,000
Tom Bennett, Royal Society (Mar 2017), £15,000
Ryan Seipke, BBSRC (Feb 2017), £52,116
Mary O'Connell, BBSRC (Feb 2017), £46,986
Hannah Dugdale, NERC (Feb 2017), £504,138
Anastasia Zhuravleva, EPSRC (Jan 2017), £100,792
Richard Bayliss, Cancer Research UK (Jan 2017), £1,600,000
John Barr, EU (Jan 2017), £339,000
Mark Harris, Royal Society (Jan 2017), £250,000
Alison Dunn, NERC (Jan 2017), £105,000
Alex Breeze, Pancreatic Cancer Research Fund (Jan 2017), £180,000
Alison Dunn, NERC (Dec 2016), £18,000
Lisa Collins, BBSRC (Dec 2016), £1,681,835
Brendan Davies, Leverhulme Trust (Dec 2016), £247,555
Alan Benson, Mark Drinkhill, Ed White, British Heart Foundaion (Dec 2016), £217,223
Adrian Goldman, Royal Society (Dec 2016), £82,999
Lisa Roberts, Alex Breeze, Brendan Davies, Timothy Devinney, Oliver Harlen, Joseph Holden, Anthea Hucklesby, Pamela Jones, Philip Mellor, RCUK (Nov 2016), £484,172
Lisa Roberts, Alex Breeze, Brendan Davies, Timothy Devinney, Oliver Harlen, Joseph Holden, Anthea Hucklesby, Pamela Jones, Philip Mellor, Wellcome Trust (Nov 2016), £119,343
Katie Field, Rank Prize Funds (Nov 2016), £20,000
Jessica Kwok, Royal Society (Nov 2016), £14,948
John Ladbury, Cancer Research UK (Oct 2016), £4,250
Miriam Wittmann, Martin Stacey, Edward Vital, Lupus UK
(Oct 2016), £34,010
Valerie Speirs, NC3Rs
(Oct 2016), £90,000
Nicola Stonehouse, Morgan Herod, David Rowlands, BBSRC
(Sep 2016), £436,424
Joseph Cockburn, Wellcome Trust
(Sep 2016), £100,000
John Barr, Public Health England
(Sep 2016), £94,471
Helen Miller, DSM Nutritional Products A/S
(Sep 2016), £54,680
Steven Clapcote, Vitaflo International Ltd
(Sep 2016), £39,285
Juan Fontana Jordan De Urries
, Royal Society
(Sep 2016), £21,793
Jing Li, Sarah Calaghan, Mark Drinkhill, British Heart Foundation
(Sep 2016), £117,585